Congress returned to Capitol Hill this week to deal with Fiscal Year 2017 (FY17) appropriations and funding the domestic response to Zika. With fewer than 20 days remaining in the Congressional schedule before the election and FY16 ending on September 30, little time remains for Congress to address these issues. Earlier this week, Senate Democrats…

Read More

Last week, the White House requested that unobligated Ebola funding be reprogrammed to combat the Zika virus. The President had previously requested $1.9 billion emergency funding, but the request had stalled as Republican appropriators pushed for the use of unobligated funds. It is unclear which accounts the funding will come from. It is expected that…

Read More

In early March, the Senate Health, Education, Labor and Pensions (HELP) Committee approved the “Adding Zika Virus to the FDA Priority Review Voucher Program Act” (S.2152). The bill has now been referred to the House Committee on Energy and Commerce. During the hearing Senator Susan Collins (R-ME) spoke about her legislation “Increasing Competition in Pharmaceuticals…

Read More

As the International AIDS Conference returns to the U.S., Craig Moscetti shares some of the names that will shape the agenda Today the organizers of the XIX International AIDS Conference (IAC) announced 15 plenary speakers and presentations that will help shape the overall conference theme “Turning the Tide Together.” Many global health advocates are excited to see…

Read More

J&J Director of Contributions on the importance of leveraging the simple intervention of handwashing to achieve health outcomes: A colleague of mine recently wrote about a woman in Nicaragua who went in search of a small loan, and ended up being treated for cervical cancer, because a microcredit organization arranged for a health screening to coincide with…

Read More

Dr. Anthony Fauci has spent virtually his entire career as director of the National Institute of Allergy and Infectious Diseases at NIH tracking the AIDS epidemic. In a session on the advancement of science and research on HIV, he gave an insightful overview of the early days when key discoveries were made but it was…

Read More

This is a guest blog by Meredith Mazzotta of Science Speaks, the blog of the Center for Global Health Policy. ROME  — Drug companies are excluding middle-income countries – such as Brazil, Thailand, India, Columbia and China – from HIV drug discount programs where drug prices can be as much as ten times higher, according to…

Read More